Skip to main content
Kothari Fermanatation & Biochem Ltd logo

Kothari Fermanatation & Biochem Ltd — Investor Relations & Filings

Ticker · 507474 ISIN · INE991B01010 BSE.NS Manufacturing
Filings indexed 323 across all filing types
Latest filing 2022-03-28 Regulatory Filings
Country IN India
Listing BSE.NS 507474

About Kothari Fermanatation & Biochem Ltd

https://www.kothariyeast.in

Kothari Fermentation & Biochem Ltd specializes in the production of yeast and yeast-based derivatives through advanced fermentation technology. The company's primary product portfolio includes compressed yeast, dried yeast, and instant dry yeast, marketed under the brand name Sunrise. These products cater extensively to the bakery and food processing industries. Additionally, the firm operates in the biochemical sector, producing industrial alcohol, extra neutral alcohol, and rectified spirits. Utilizing integrated manufacturing processes, the company focuses on high-quality biochemical solutions for diverse industrial applications, including the beverage and pharmaceutical sectors. Its operations emphasize technical precision in fermentation to ensure product consistency and performance in commercial baking and industrial fermentation processes.

Recent filings

Filing Released Lang Actions
This is to inform you that pursuant to the provisions of the Securities And Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's code of conduct ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Bombay Stock Exchange regarding the closure of the trading window for insiders due to the upcoming declaration of audited financial results for the quarter/year ended March 31, 2022. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and informs about the trading window closure period. The document does not contain any financial data, results, or detailed report content itself. It is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1371 characters), and it serves as an intimation or notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements and compliance notices that do not fit other specific categories.
2022-03-28 English
Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Please find enclosed herewith a copy of the letter sent to ....
Regulatory Filings
2022-02-19 English
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at their Meeting held on 14th February, ....
Regulatory Filings
2022-02-14 English
KOTHARI FERMENTATION & BIOCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve Pursuant to ....
Regulatory Filings
2022-02-04 English
This is to inform you that Kothari Fermentation and Biochem Limited is in the process of launching its new product Yeast Extract Powder and Mono Oligo Saccharides (Mannan and Beta Glucan). ....
Capital/Financing Update Classification · 90% confidence The document is a disclosure under Regulation 30 addressed to the Bombay Stock Exchange. It announces the launch of new products and the establishment of a new production plant. There is no financial data, no report attached or referenced, and the content is an update on business activities. Regulation 30 disclosures typically relate to material events or information that companies must disclose to stock exchanges. This fits the category of Capital/Financing Update (CAP) as it involves business expansion and product launch information relevant to investors and the market.
2022-01-12 English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the Certificate received from M/s Abhipra Capital Limited, ....
Regulatory Filings
2022-01-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.